Verthermia

Henderson, United States Founded: 2012 • Age: 14 yrs
Cancer treatment is enabled through a hyperthermia therapeutic platform.
Annual revenue - Latest available
Total funding $2.0M 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Verthermia

Verthermia is a company based in Henderson (United States) founded in 2012. Verthermia has raised $2 million across 1 funding round. Verthermia operates in a competitive market with competitors including ElmediX, Sensius, Siva Therapeutics, MagHeals and MagForce, among others.

  • Headquarter Henderson, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Verthermia, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $2 M (USD)

    in 1 rounds

  • Latest Funding Round
    $2 M (USD), Seed

    Jan 20, 2021

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Verthermia

Verthermia has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Seed round of $2 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Verthermia

Investments
Premium access

Investment portfolio details for Verthermia

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Verthermia

Premium access

Detailed financials for Verthermia

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Verthermia Comparisons

Verthermia Primary company
Description
Cancer treatment is enabled through a hyperthermia therapeut...
Location
Henderson, United States
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Verthermia

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Verthermia

Verthermia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ElmediX, Sensius, Siva Therapeutics, MagHeals and MagForce, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of the device for treating pancreatic cancer
Locked Locked Locked
Developer of a hyperthermia system for cancer treatment. This system uses thermotherapy, a controlled heating process, to target tumors while preserving surrounding healthy tissue. The technology is designed to be integrated with existing radiotherapy workflows, offering improved clinical outcomes and enhanced quality of life for patients. The system is currently in development, with prototypes undergoing clinical trials. Future applications are planned for various cancer types.
Locked Locked Locked
Gold nanoparticle hyperthermia technology for cancer therapy is developed.
Locked Locked Locked
Magnetic hyperthermia devices for non-invasive cancer treatment are provided.
Locked Locked Locked
Medical devices utilizing magnetic hyperthermia for cancer treatment are developed.
Premium access

Detailed competitors of Verthermia

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Verthermia

Premium access

Complete news archive for Verthermia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Verthermia

Verthermia was founded in 2012 and raised its 1st funding round 9 years after it was founded.

Verthermia is headquartered in Henderson, United States. It is registered at Henderson, Nevada, United States.

Mitchel K May is the current CEO of Verthermia.

Verthermia is a funded company, having raised a total of $2M across 1 funding round to date.

Verthermia was established in 2012 and is based in Henderson, United States. A platform for hyperthermia-based therapy is developed and supplied to address cancer. Focus is placed on oncology applications within the health technology sector. Operations involve the integration of hyperthermia methods to support conventional treatments. Services encompass platform deployment for clinical use across relevant geographies.

Verthermia's top competitors include Sensius, MagHeals and Siva Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available